We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGNI icon
7526
PUT
Magnite
MGNI
$3.53B
$40K ﹤0.01%
+21,500
New +$53.7K
URG
7527
Ur-Energy
URG
$541M
$40K ﹤0.01%
58,517
+5,441
+10% +$3.31K
CSCI
7528
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$40K ﹤0.01%
168
-13
-7% -$2.71K
BETS
7529
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
CFMS
7530
DELISTED
Conformis, Inc. Common Stock
CFMS
$40K ﹤0.01%
664
-3,895
-85% -$311K
ZN
7531
PUT
DELISTED
Zion Oil & Gas, Inc.
ZN
$40K ﹤0.01%
18,600
+5,200
+39% +$12.7K
EPE
7532
PUT
DELISTED
EP Energy Corporation
EPE
$40K ﹤0.01%
16,900
+1,300
+8% +$3.11K
CASC
7533
DELISTED
Cascadian Therapeutics, Inc.
CASC
$40K ﹤0.01%
10,792
-5,334
-33% -$21.8K
CHNR icon
7534
China Natural Resources
CHNR
$5.26M
$39K ﹤0.01%
+364
New +$35.1K
GNSS icon
7535
Genasys
GNSS
$78.8M
$39K ﹤0.01%
+15,659
New +$33.5K
OTIV
7536
DELISTED
OTI On Track Innovations Ltd
OTIV
$39K ﹤0.01%
+28,366
New +$36.9K
CATX icon
7537
Perspective Therapeutics
CATX
$350M
$38K ﹤0.01%
9,427
+6,437
+215% +$30K
CBAT icon
7538
CBAK Energy Technology Ltd
CBAT
$65.6M
$38K ﹤0.01%
25,034
-2,231
-8% -$3.83K
FOCL
7539
EDAP TMS S.A.
FOCL
$173M
$38K ﹤0.01%
+13,294
New +$39.6K
EMX
7540
DELISTED
EMX Royalty
EMX
$38K ﹤0.01%
46,023
+27,959
+155% +$21.8K
FCEL icon
7541
FuelCell Energy
FCEL
$1.68B
$38K ﹤0.01%
+62
New +$43K
OESX icon
7542
Orion Energy Systems
OESX
$78.1M
$38K ﹤0.01%
+4,277
New +$39.3K
IRD
7543
Opus Genetics
IRD
$302M
$38K ﹤0.01%
+390
New +$39.6K
SUNE
7544
SUNation Energy
SUNE
$10.5M
0
UQM
7545
DELISTED
UQM Technologies, Inc.
UQM
$38K ﹤0.01%
+27,244
New +$34.8K
STLY
7546
DELISTED
Stanley Furniture Co Inc
STLY
$38K ﹤0.01%
43,130
+26,886
+166% +$26.7K
EMMS
7547
DELISTED
Emmis Communications Corp
EMMS
$38K ﹤0.01%
+11,433
New +$37.9K
BDSI
7548
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$38K ﹤0.01%
12,900
+2,700
+26% +$7.46K
OREX
7549
CALL
DELISTED
Orexigen Therapeutics, Inc.
OREX
$38K ﹤0.01%
29,500
+17,200
+140% +$28K
CVM icon
7550
CEL-SCI Corp
CVM
$27.1M
$37K ﹤0.01%
+652
New +$35.1K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.